![Troy Ignelzi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Troy Ignelzi
Directeur Financier/CFO chez
RAPPORT THERAPEUTICS, INC.
Fortune : 520 800 $ au 30/09/2026
Profil
Mr. Troy A. Ignelzi is an Independent Director at Harmony Biosciences Holdings, Inc., an Independent Director at Contineum Therapeutics, Inc., a Chief Financial Officer at Rapport Therapeutics, Inc., an Executive Advisor at Sofinnova Investments, Inc. and an Independent Director at Abivax SA. He is on the Board of Directors at Harmony Biosciences Holdings, Inc., Contineum Therapeutics, Inc. and Abivax SA.
Mr. Ignelzi was previously employed as an Independent Director by CinCor Pharma, Inc., a Chairman by Vedanta Biosciences, Inc., a Chief Financial Officer by Karuna Therapeutics, Inc., a Chief Financial & Accounting Officer by scPharmaceuticals, Inc., a Chief Financial Officer by Juventas Therapeutics, Inc., a Senior VP-Operations & Business Development by PharmaLex GmbH, a Vice President by Esperion Therapeutics, Inc., and a VP-Business Development & Strategic Planning by InSys Therapeutics, Inc. /Old/.
He received his undergraduate degree from Ferris State University (Michigan).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/10/2026 | 15 500 ( 0,03 % ) | 520 800 $ | 30/09/2026 | |
| 26/06/2026 | 0 ( -.--% ) | - $ | 30/09/2026 | |
| 02/04/2026 | 0 ( -.--% ) | - $ | 30/09/2026 | |
ABIVAX SA -.--% | 28/02/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
Postes actifs de Troy Ignelzi
| Sociétés | Poste | Début |
|---|---|---|
| ABIVAX | Directeur/Membre du Conseil | 11/07/2023 |
| RAPPORT THERAPEUTICS, INC. | Directeur Financier/CFO | 01/11/2023 |
| CONTINEUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 20/05/2024 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Directeur/Membre du Conseil | 02/04/2026 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Private Equity Investor | 01/11/2023 |
Anciens postes connus de Troy Ignelzi
| Sociétés | Poste | Fin |
|---|---|---|
| KARA THER | Directeur Financier/CFO | 29/09/2023 |
| CINCOR PHARMA, INC. | Directeur/Membre du Conseil | 24/02/2023 |
| SCPHARMACEUTICALS INC. | Directeur Financier/CFO | 28/02/2019 |
Juventas Therapeutics, Inc.
 Juventas Therapeutics, Inc. BiotechnologyHealth Technology Develops regenerative and gene therapies to treat advanced cardiovascular diseases | Directeur Financier/CFO | 01/02/2016 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Troy Ignelzi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Ferris State University (Michigan)
 Ferris State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InSys Therapeutics, Inc. /Old/
 InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products | Health Technology |
Juventas Therapeutics, Inc.
Juventas Therapeutics, Inc. BiotechnologyHealth Technology Develops regenerative and gene therapies to treat advanced cardiovascular diseases | Health Technology |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
PharmaLex GmbH
 PharmaLex GmbH Packaged SoftwareTechnology Services Develops AI and machine learning automation for pharmacy, biotech & med tech industries | Technology Services |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
